Key facts
- Notable investors include Lotus Lake Ventures, Beijing FOF Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for BodiHekang
- ·The full record, as it builds
Funding rounds
No funding rounds for BodiHekang are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BodiHekang
Provider of biomedical research and development services intended to develop engineered cell therapies and oral small-molecule drugs to restore immune tolerance. The company offers development and provision of biomedical technologies and consulting services, thereby enabling pharmaceutical developers to overcome limitations of conventional treatments.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2021
- Website
- benethera.com/
- Ownership
- Privately Held (backing)
BodiHekang doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BodiHekang shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BodiHekang in its N-PORT filings yet. We sweep new filings monthly.